v3.25.4
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 568,087 $ 573,280 $ 512,345
Cost of sales (including depreciation and amortization of $41,251, $41,882 and $48,503, respectively) 179,930 185,054 184,152
Gross profit 388,157 388,226 328,193
Selling, general and administrative expense 314,026 343,798 303,879
Research and development expense 12,113 13,951 13,446
Restructuring costs 2,235 (52) 840
Change in fair value of contingent consideration 0 1,423 719
Depreciation and amortization 5,727 7,652 8,842
Impairment of assets 0 36,357 78,615
Loss on disposals 81 292 3,577
Operating income (loss) 53,975 (15,195) (81,725)
Interest expense, net 26,486 38,792 40,676
Loss on extinguishment 326 0 0
Other expense (income) 1,454 (1,645) (1,290)
Other expense 28,266 37,147 39,386
Income (loss) before income taxes 25,709 (52,342) (121,111)
Income tax (benefit) expense, net (1,565) (5,293) 85
Net income (loss) from continuing operations 27,274 (47,049) (121,196)
Loss from discontinued operations, net of tax 0 0 (74,429)
Net income (loss) 27,274 (47,049) (195,625)
(Income) loss attributable to noncontrolling interest - continuing operations (4,542) 10,924 24,458
Loss attributable to noncontrolling interest - discontinued operations 0 0 14,937
Net income (loss) attributable to Bioventus Inc. 22,732 (36,125) (156,230)
Change in prior service cost and unrecognized gain (loss) for defined benefit plan adjustment 21 13 (8)
Change in foreign currency translation adjustments 1,806 (4,194) 1,140
Change in the fair value of cash flow hedges (991) 0 0
Comprehensive income (loss) 28,110 (51,230) (194,493)
Comprehensive (income) loss attributable to noncontrolling interest - continuing operations (4,705) 11,738 24,230
Comprehensive loss attributable to noncontrolling interest - discontinued operations 0 0 14,937
Comprehensive income (loss) attributable to Bioventus Inc. $ 23,405 $ (39,492) $ (155,326)
Income (loss) per share of Class A common stock from:      
Continuing operations, basic (in dollars per share) $ 0.34 $ (0.56) $ (1.54)
Discontinued operations, basic (in dollars per share) 0 0 (0.95)
Basic income (loss) per Class A common stock (in dollars per share) 0.34 (0.56) (2.49)
Continuing operations, diluted (in dollars per share) 0.33 (0.56) (1.54)
Discontinued operations, diluted (in dollars per share) 0 0 (0.95)
Diluted income (loss) per Class A common stock (in dollars per share) $ 0.33 $ (0.56) $ (2.49)
Weighted-average shares of Class A common stock outstanding:      
Basic (in shares) 66,622,631 64,547,474 62,647,554
Diluted (in shares) 68,914,895 64,547,474 62,647,554